Wednesday, September 15th – 12:30 PM EST
Digital Event: |
Overview:
Join Thomas Busby, Vice President at Outcome Capital, for a discussion on creating safe, usable medical device solutions– from the early prototyping phase to proof-of-concept. For more information, please contact |
The New Orleans biotech is currently raising a tiny $8 million Series A to develop its non-opioid painkiller. It keeps costs low by paying employees cash on an hourly basis—but no salaries.
Read MoreOutcome Capital Life Science Market Pulse March 2025 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?